Showing results (241-250 of 861) with videos related to

Sort By:
Pageof 87
Lupus Science & Medicine|February 12, 2025
Long-term safety and efficacy of the combination of belimumab and rituximab in the treatment of severe and refractory SLE: a preliminary reportMieke van Schaik, Eline J Arends, Marjolein J A L Wetzels, et al.
Lupus Science & Medicine|February 26, 2025
Mortality patterns of SLE and the associated risk factors in Korean patients: a nationwide cohort studySoo-Kyung Cho, Yena Jeon, Jung-Hyo Kim, et al.
Lupus Science & Medicine|February 11, 2025
Association of race and ethnicity with mortality in adults with SLE: a systematic literature review and meta-analysisSamir Patel, Zijing Yang, Deepak Nagra, et al.
Lupus Science & Medicine|August 31, 2024
Monoclonal gammopathy in systemic lupus erythematosus is associated with distinctive clinical course, malignancy and mortality rate: a single-centre retrospective cohort studyAndzelika Siwiec-Kozlik, Pawel Kozlik-Siwiec, Magdalena Spalkowska, et al.
Lupus Science & Medicine|August 1, 2024
Meeting report: patient and caregiver recommendations for a mobile health application for paediatric systemic lupus erythematosusKatrina Guardino, Malaya Gaerlan, Caitlan S Pinotti, et al.
Lupus Science & Medicine|December 29, 2022
Autoantibodies associated with systemic sclerosis in three autoimmune diseases imprinted by type I interferon gene dysregulation: a comparison across SLE, primary Sjögren's syndrome and systemic sclerosisRama Andraos, Awais Ahmad, Per Eriksson, et al.
Lupus Science & Medicine|November 30, 2022
Evaluating disease control following belimumab treatment in patients with SLE enrolled in the US OBSErve studyJacob N Hunnicutt, Jolyon Fairburn-Beech, Mary Elizabeth Georgiou, et al.
Lupus Science & Medicine|July 13, 2021
LUPUS-BEST-treat-to-target in systemic lupus erythematosus: study protocol for a three-armed cluster-randomised trialJohanna Mucke, Oliver Kuss, Ralph Brinks, et al.
Lupus Science & Medicine|February 2, 2018
Associations between type I interferon and antiphospholipid antibody status differ between ancestral backgroundsTaro Iwamoto, Jessica Dorschner, Meenakshi Jolly, et al.
Lupus Science & Medicine|May 24, 2022
Real-world burden of systemic lupus erythematosus in the USA: a comparative cohort study from the Medical Expenditure Panel Survey (MEPS) 2016-2018Shannon Grabich, Eileen Farrelly, Robert Ortmann, et al.
Pageof 87